The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

By Stephanie Brown HealthDay ReporterTUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has ...

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 ...

The Food and Drug Administration approved Moderna's next-generation COVID-19 vaccine for adults 65 and older, the company ...

Jefferies analysts said the approval was largely expected and an “incremental positive” for Moderna amid questions about the ...

The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...

The Centers for Disease Control and Prevention will no longer recommend that healthy children and pregnant women receive the COVID-19 vaccine, the Trump administration announced Tuesday. “Last ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

The new vaccine, mNexspike (mRNA-1283), is a step toward next-generation coronavirus vaccines. It’s made in a way that allows ...

The US Department of Health and Human Services is no longer recommending COVID vaccines for pregnant women and children. Big ...

The FDA’s approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna ...

Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.